Poland – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – Delivery of the radiopharmaceutical vipivotide lutetium tetraxanthene (177Lu)
TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Description & Project Overview
The subject of the order is the supply of the radiopharmaceutical drug vipivotidutetraxanthene lutetium (177Lu). A detailed description of the subject of the order is specified in the price form, which constitutes Annex No. 2A and in the contract template - Annex No. 1 to the SWZ. The Ordering Party does not allow the possibility of submitting partial offers - number of tasks: 1.